Fortive
Search results
We’re Danaher - a leading global life sciences and diagnostics innovator, committed to accelerating the power of science and technology to improve human health. From our environment to our associates, we’re determined to create positive impact that accelerates greater progress.
In January 1993, Danaher formed NMTC, Inc., which acquired a substantial portion of the assets of MTC, including the existing distributorship agreements of MTC. Within two years of Danaher's founding in 1984, Danaher acquired 12 companies as part of a strategy to enter the manufacturing business.
Danaher is comprised of more than 15 diverse businesses across Biotechnology, Diagnostics, and Life Sciences. Learn more about the Danaher companies.
Danaher Corporation (NYSE: DHR) ("Danaher" or the "Company"), the global life sciences and diagnostics innovator, today published its 2024 Sustainability Report which conveys the depth and scope... View all news
Danaher is a leading global life sciences and diagnostics innovator, helping to solve many of the world’s most important health challenges. Ultimately improving quality of life for billions of people today, while setting the foundation for a healthier, more sustainable tomorrow.
At Danaher, you’ll accelerate your career while driving innovation that improves lives. Learn about our open jobs and career paths across the world.
Jan 30, 2024 · WASHINGTON, Jan. 30, 2024 / PRNewswire / -- Danaher Corporation (NYSE: DHR) (the "Company") today announced results for the fourth quarter and full year 2023. All results in this release reflect only continuing operations unless otherwise noted. Key Fourth Quarter 2023 Results.
Danaher is a leading global life sciences and diagnostics innovator, committed to accelerating the power of science and technology to improve human health. We partner with customers across the ...
Danaher Corporation (NYSE: DHR) (the "Company") today announced results for the quarter ended June 28, 2024. All results in this release reflect only continuing operations unless otherwise noted.... Danaher Announces Two New Centers of Innovation in Diagnostics to Transform Precision Medicine Development.
Danaher Corporation (NYSE: DHR) (the "Company") today announced results for the quarter ended March 29, 2024. All results in this release reflect only continuing operations unless otherwise noted. Read more
